# Bristol-Myers Squibb Company - Inspection Records Source: https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92 > Inspection records and compliance data for Bristol-Myers Squibb Company in Madison, New Jersey. Access full analysis and detailed observations. --- ## Details - Name: Bristol-Myers Squibb Company - FEI Number: 3004991673 - City: Madison - State: New Jersey - Country Name: United States - Address Line 1: 5 Giralda Farms - Zip Code: 07940 ## Related Documents - [483 - Bristol-Myers Squibb Company - 2025-07-18](https://www.keypedia.com/records/483/bristol-myers-squibb-company/3f16d573-7ac8-419f-9ff4-2b070cead434) — source: FDA, date: July 18, 2025 - [FDA Inspection 1275526 - Bristol-Myers Squibb Company - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/e6f01d89-0a13-4fb3-a74e-dfb41429a3bc) — source: FDA, date: July 18, 2025 - [FDA Inspection 1275526 - Bristol-Myers Squibb Company - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/388f57dd-7839-42b2-906e-2074e1ea5c67) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2025 - [483 - Bristol-Myers Squibb Company - 2024-12-06](https://www.keypedia.com/records/483/bristol-myers-squibb-company/97218ac0-74e3-4a85-83a2-081a9e0504fb) — source: FDA, date: December 6, 2024 - [FDA Inspection 1236864 - Bristol-Myers Squibb Company - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/41559cd5-b35e-471a-8003-1db4082c038a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024 - [FDA Inspection 1236864 - Bristol-Myers Squibb Company - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/0bfe5373-cbf9-4df1-b1ab-e2551263381b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024 - [FDA Inspection 1247735 - Bristol-Myers Squibb Company - 2024-09-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/8b2d9f5e-ffa4-4616-873b-3175ce2dc81d) — source: FDA, date: September 6, 2024 - [FDA Inspection 1247735 - Bristol-Myers Squibb Company - 2024-09-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/b8ae4944-d185-4142-8468-e00f31678546) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2024 - [FDA Inspection 1228973 - Bristol-Myers Squibb Company - 2024-01-31](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/392beb1b-a516-464d-9e4f-285e3a611cb3) — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2024 - [483 - Bristol-Myers Squibb Company - 2023-06-16](https://www.keypedia.com/records/483/bristol-myers-squibb-company/4ea843bb-7d44-433b-b1f8-807afaf7865e) — source: FDA, date: June 16, 2023 - [FDA Inspection 1208871 - Bristol-Myers Squibb Company - 2023-06-16](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/ad863020-b34a-40d2-91ba-237fdca75cc3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2023 - [EIR - Bristol-Myers Squibb Company - 2022-03-14](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/d539f239-1103-4fe2-acdf-a6f28938d6e1) — source: FDA, date: March 14, 2022 - [FDA Inspection 1165563 - Bristol-Myers Squibb Company - 2022-03-14](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/3425021c-e05a-405a-b49d-269fd28c5388) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2022 - [483 - Bristol-Myers Squibb Company - 2021-02-19](https://www.keypedia.com/records/483/bristol-myers-squibb-company/de025911-4ac0-4553-854c-d1edad23420a) — source: FDA, date: February 19, 2021 - [FDA Inspection 1124151 - Bristol-Myers Squibb Company - 2020-06-03](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/c8363c9c-7f54-4f25-b4f8-ff3f17397cc1) — classification: No Action Indicated (NAI), source: FDA, date: June 3, 2020 - [483 - Bristol-Myers Squibb Company - 2017-01-25](https://www.keypedia.com/records/483/bristol-myers-squibb-company/d9ab1e53-7ce9-4a8c-b38e-01f5e565a0ed) — source: FDA, date: January 25, 2017 - [483 - Bristol-Myers Squibb Company - 2012-07-30](https://www.keypedia.com/records/483/bristol-myers-squibb-company/10c364b5-0a3f-4a9c-9052-a72355ca9483) — source: FDA, date: July 30, 2012 - [483 - Bristol-Myers Squibb Company - 2010-03-19](https://www.keypedia.com/records/483/bristol-myers-squibb-company/b6214f1f-de9b-4681-8439-78f3587411b7) — source: FDA, date: March 19, 2010 - [EIR - Bristol-Myers Squibb Company - 2006-08-14](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/991b0c74-c74b-45a6-915a-36b05b26ce5d) — source: FDA, date: August 14, 2006 ## Related Companies - [ALK-Abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981) - [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70) - [Zoetis LLC](https://www.keypedia.com/companies/zoetis-llc/1ea95bb9-fb5b-458d-bfff-ca0195c13aa6) - [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f) - [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369) - [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf) - [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861) - [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356) - [BioMarin International Limited](https://www.keypedia.com/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4) - [Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)](https://www.keypedia.com/companies/daewoong-pharmaceutical-co-ltd-hyangnam-factory/2f9e6a6a-9f69-4377-b1ef-5500338ce477) ## Related Officers - [issuing_officer](https://www.keypedia.com/people/amalia-c-himaya/36a0063f-06c2-49d9-913b-8673e1707d1e) - [investigator](https://www.keypedia.com/people/russ-e-davis/435f3b42-ff8a-48f0-9e78-186faa937d74) - [recipient](https://www.keypedia.com/people/david-damrau/1aa8cd99-7193-4b57-8621-d87bd7f6c2a0) - [company_representative](https://www.keypedia.com/people/erin-conlin/5dbe1359-097d-4cb2-8c52-9092f37003d8) - [investigator](https://www.keypedia.com/people/kimberly-l-schultz/2d000290-f49c-4cfd-b8f8-3f4d71f76324) - [Linda Thur, CSO](https://www.keypedia.com/people/linda-thur-cso/4f1069c7-1580-424a-a86c-15b104652464)